Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 34
Filter
Add more filters










Publication year range
1.
Neurologia (Engl Ed) ; 35(3): 165-169, 2020 Apr.
Article in English, Spanish | MEDLINE | ID: mdl-29029824

ABSTRACT

INTRODUCTION: Neuroinflammation has recently been described in amyotrophic lateral sclerosis (ALS). However, the precise role of such proinflammatory cytokines as monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1ß (MIP-1ß) in ALS has not yet been determined. In this study, we determined cerebrospinal fluid (CSF) MCP-1 and MIP-1ß levels and assessed their association with the duration and severity of ALS. METHODS: Concentrations of MCP-1 and MIP-1ß were determined in the CSF of 77 patients diagnosed with ALS and 13 controls. Cytokine levels were analysed in relation to ALS duration (<12months vs. >12months) and severity (<30points vs. >30points on the ALS Functional Rating Scale administered at hospital admission). RESULTS: Higher CSF MIP-1ß (10.68pg/mL vs. 4.69pg/mL, P<.0001) and MCP-1 (234.89pg/mL vs. 160.95pg/mL, P=.011) levels were found in the 77 patients with ALS compared to controls. There were no differences in levels of either cytokine in relation to disease duration or severity. However, we did observe a significant positive correlation between MIP-1ß and MCP-1 in patients with ALS. CONCLUSIONS: The increase in MIP-1ß and MCP-1 levels suggests that these cytokines may have a synergistic effect on ALS pathogenesis. However, in our cohort, no association was found with either the duration or the clinical severity of the disease.


Subject(s)
Amyotrophic Lateral Sclerosis/cerebrospinal fluid , Chemokine CCL2/cerebrospinal fluid , Chemokine CCL4/cerebrospinal fluid , Peptide Fragments/cerebrospinal fluid , Adult , Female , Humans , Male , Middle Aged
3.
Bioorg Med Chem Lett ; 12(23): 3475-8, 2002 Dec 02.
Article in English | MEDLINE | ID: mdl-12419387

ABSTRACT

Several thiosemicarbazone derivatives of 5-nitrothiophene-2-carboxaldehyde were prepared by the simple process in which N(4)-thiosemicarbazone moiety was replaced by aliphatic, arylic and cyclic amine. Among these thiosemicarbazones compound 11 showed significant antiamoebic activity whereas compound 3 was more active antitrichomonal than the reference drug.


Subject(s)
Aldehydes/chemistry , Antiprotozoal Agents/chemical synthesis , Antiprotozoal Agents/pharmacology , Sulfhydryl Compounds/chemistry , Thiosemicarbazones/chemistry , Thiosemicarbazones/pharmacology , Aldehydes/pharmacology , Amines/chemistry , Animals , Entamoeba histolytica/drug effects , Giardia lamblia/drug effects , Inhibitory Concentration 50 , Parasitic Sensitivity Tests , Structure-Activity Relationship , Sulfhydryl Compounds/pharmacology , Trichomonas vaginalis/drug effects
4.
Bioorg Med Chem Lett ; 12(6): 869-71, 2002 Mar 25.
Article in English | MEDLINE | ID: mdl-11958982

ABSTRACT

Reaction of [MoO(2)(acac)(2)] (where, acac=acetyl acetone) and KVO(3) with 2-(salicylidieneimine) benzimidazole lead to form new complexes [MoO(2)(sal-BMZ)(2)] and K [VO(2)(sal-BMZ)(2)] [where, sal-BMZ=2-(salicylidieneimine) benzimidazole], which showed the monobasic bidentate nature of the ligand in which the phenolic oxygen and the imine nitrogen of the ligand are coordinated to the metal ion. These complexes were characterized along with nine other complexes of oxoperoxovanadium (V), molybdenum (Vl) and tungsten (Vl) with benzimidazole derivatives and screened in vitro by micro dilution technique for their amoebicidal activity with a view to search for a more effective agent against Entamoeba histolytica suggests that compound 2 and 3 might be endowed with important antiamoebic properties since they showed IC(50 )values in a microM range.


Subject(s)
Amebicides/chemical synthesis , Benzimidazoles/chemical synthesis , Amebicides/pharmacology , Animals , Benzimidazoles/pharmacology , Entamoeba histolytica/drug effects , Inhibitory Concentration 50 , Ligands , Molybdenum/chemistry , Organometallic Compounds/chemical synthesis , Organometallic Compounds/pharmacology , Structure-Activity Relationship , Vanadium/chemistry
5.
Bioorg Med Chem Lett ; 11(20): 2675-8, 2001 Oct 22.
Article in English | MEDLINE | ID: mdl-11591499

ABSTRACT

Reaction of new thiosemicarbazones (1-4) derived from thiophene-2-carboxaldehyde and cycloalkylaminothiocarbonylhydrazine with [Ru(eta(4)-C8H12)(CH3CN)2Cl2] leads to form complexes (1a-4a) of the type [Ru(eta(4)-C8H12)(TSC)Cl2] (where TSC=thiosemicarbazone). All the compounds have been characterised by elemental analysis, IR, 1H NMR, electronic spectra and thermogravimetric analysis. It is concluded that the thionic sulphur and the azomethine nitrogen atom of the ligands are bonded to the metal ion. In vitro antiamoebic screening against (HK-9) strain of Entamoeba histolytica indicated that the Ru(II) complexes of thiophene-2-carboxaldehyde thiosemicarbazones were found more active than the thiosemicarbazones.


Subject(s)
Antiprotozoal Agents/chemical synthesis , Thiosemicarbazones/chemical synthesis , Animals , Antiprotozoal Agents/chemistry , Antiprotozoal Agents/pharmacology , Entamoeba histolytica/drug effects , Parasitic Sensitivity Tests , Ruthenium/chemistry , Thiosemicarbazones/chemistry , Thiosemicarbazones/pharmacology
9.
Parasitol Res ; 86(12): 1018-21, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11133106

ABSTRACT

Entamoeba histolytica grows in media without serum but with a mixture of aminoacids, vitamins, lipoproteins, free cholesterol, phospholipids and fatty acids called PACSR. The ability of lipoproteins and free lipids to support growth of three E. histolytica strains (HK9, HMI:IMSS and HM3:IMSS) was analysed. Tubes containing 5 ml culture medium, amino acids, vitamins and either 120-1,200 microg lipoproteins/ml or 0.017-0.10 mg free lipids/ml (predissolved in absolute ethanol) were inoculated with 1x10(4) trophozoites/ml and incubated at 37 degrees C for 72 h. Amoebae died within 12 h in the presence of any free lipid combination, while those having 240-480 mg lipoproteins/ml reached densities similar to or higher than those of controls (depending on strain). The addition of ethanol (0.1%) to the media produced stable lipid solutions and did not show significant adverse effects. Accordingly, E. histolytica is auxotrophic to lipoproteins and unable to use free cholesterol, phospholipids or fatty acids.


Subject(s)
Entamoeba histolytica/growth & development , Lipoproteins/metabolism , Animals , Cholesterol/metabolism , Cholesterol/pharmacology , Culture Media , Culture Media, Serum-Free , Entamoeba histolytica/metabolism , Fatty Acids/metabolism , Fatty Acids/pharmacology , Lipid Metabolism , Lipids/pharmacology , Lipoproteins/pharmacology , Phospholipids/metabolism , Phospholipids/pharmacology
10.
Arch Med Res ; 30(4): 298-302, 1999.
Article in English | MEDLINE | ID: mdl-10573631

ABSTRACT

BACKGROUND: Several factors inhibit cellular immune response by deactivating macrophages, but very few, such as those described here, prevent macrophage activation. METHODS: Ascites liquid from 12-day-old BALB/c mice bearing 5178Y lymphoma tumors was collected, and cell-free ascites liquid (CFAL) was separated from lymphoblasts. The supernatant (S1) was obtained from the homogenized and centrifuged lymphoblasts. Then, macrophage cultures containing 0.2 x 10(6) cells from lymphoma-bearing or healthy mice were added to 10 microL of CFAL or S1, plus 5 micrograms of lipopolysaccharides (LPS)/mL, 40 U interferon-gamma or a blend of both. Macrophages were incubated with CFAL or S1 prior to or after adding the activators to investigate whether any of the previously mentioned lymphoma fractions inhibited macrophage activation or whether they deactivated them. The effect of CFAL or S1 was estimated as the diminution of the amount of nitric oxide released by the experimental macrophage cultures with respect to controls (activated macrophages treated with none of the lymphoma fractions). RESULTS: LPS, IFN-gamma, and the LPS/gamma blend activated macrophages from both lymphoma-bearing and healthy mice. None of the lymphoma fractions deactivated macrophages. CFAL, but not S1, inhibited the macrophage activation, i.e., the percentage of inhibition of nitric oxide releasing 76.7% and 78.1% in macrophages from healthy and lymphoma-bearing mice, respectively. In addition, CFAL was unable to inhibit the macrophage-activation effect of IFN-gamma or the LPS/IFN-gamma blend. CONCLUSIONS: Mouse L5178Y lymphoma releases a factor that in vitro inhibits the macrophage activation induced by LPS, but not by IFN-gamma controls.


Subject(s)
Lymphoma/immunology , Macrophage Activation/immunology , Macrophages/immunology , Animals , Cells, Cultured , Interferon-alpha/pharmacology , Lipopolysaccharides/pharmacology , Macrophages/cytology , Macrophages/drug effects , Male , Mice , Mice, Inbred BALB C , Mice, Inbred DBA , Mitogens/pharmacology , Nitric Oxide/biosynthesis
14.
Arch Med Res ; 27(4): 567-9, 1996.
Article in English | MEDLINE | ID: mdl-8987196

ABSTRACT

PEHPS medium, developed for axenic cultivation of Entamoeba histolytica and E. invadens, was also capable of supporting the growth of a Trichomonas vaginalis strain, with an inoculum of 1 to 100 trichomonads/ml. The logarithmic growth phase in PEHPS or in TYI-S-33 medium lasted 72 h; yield (3.33 +/- 0.56 x 10(6) trichomonads/ml), duplication time (4.27 h), number of duplications (16.85), or increase ratio (33,328) in PEHPS medium showed no significant differences with those obtained in TYI-S-33 under similar culture conditions. Accordingly, PEHPS medium might be used for the axenic cultivation of T. vaginalis.


Subject(s)
Bacteriological Techniques , Trichomonas vaginalis/growth & development , Vaginosis, Bacterial/diagnosis , Adult , Animals , Culture Media , Female , Humans , Vaginosis, Bacterial/microbiology
15.
Contraception ; 52(6): 377-9, 1995 Dec.
Article in English | MEDLINE | ID: mdl-8749602

ABSTRACT

The effectiveness of gossypol as an antifertilizing agent is due to the severe injuries or death that this drug produces on spermatozoa and spermatides. Several in vitro and in vivo studies have shown that spermatozoal lactic and malic dehydrogenases are inhibited by gossypol; and that these are more susceptible than the somatic enzymes. Notwithstanding, the in vivo effects on other somatic enzymes have been poorly analyzed. The present study shows that gossypol did not produce toxic effects on eight erythrocytic enzymes of male hamsters that were fed daily with 20 mg of gossypol/kg, for 1, 3, 5 or 10 days. The enzymatic activities analyzed were: adenylate kinase, hexokinase, glucose-6-phosphatase, glucose phosphoisomerase, phosphofructokinase, glyceraldehyde-3-phosphate dehydrogenase, phosphoglyceratokinase and pyruvate kinase.


Subject(s)
Carbohydrate Metabolism , Erythrocytes/enzymology , Gossypol/toxicity , Spermatozoa/drug effects , Administration, Oral , Animals , Cricetinae , Erythrocytes/drug effects , Male , Spermatozoa/metabolism
16.
Parasitol Res ; 81(4): 320-3, 1995.
Article in English | MEDLINE | ID: mdl-7624291

ABSTRACT

Entamoeba histolytica phospholipase A and lysophospholipase activities from a vesicular subcellular fraction (P30) were analyzed. The products, obtained using specific substrates labeled with 14C or 3H, indicated the presence of phospholipase A1 and A2 as well as lysophospholipase L1 activities. The enzymes detected could participate in phospholipid metabolism and the alkaline phospholipase A2 may contribute to E. histolytica cytopathogenicity.


Subject(s)
Entamoeba histolytica/enzymology , Lysophospholipase/metabolism , Phospholipases A/metabolism , Animals , Calcium Chloride/pharmacology , Chromatography, Thin Layer , Entamoeba histolytica/ultrastructure , Hydrolysis , Phospholipases A/drug effects , Phospholipases A1 , Phospholipases A2 , Phospholipids/metabolism , Subcellular Fractions/enzymology
17.
J Pharm Pharmacol ; 45(2): 144-5, 1993 Feb.
Article in English | MEDLINE | ID: mdl-8095532

ABSTRACT

The in-vitro anti-amoebic effects of (+/-)-, (+)-, (-)-gossypol and emetine were tested against axenic trophozoites from five Entamoeba histolytica strains. The (-)-isomer was more active than the racemate and the (+)-isomer. These results indicate that the gossypol anti-amoebic activity is mainly due to its content of (-)-gossypol in all strains tested.


Subject(s)
Entamoeba histolytica/drug effects , Gossypol/pharmacology , Animals , Microbial Sensitivity Tests , Stereoisomerism
18.
Arch Med Res ; 24(2): 183-7, 1993.
Article in English | MEDLINE | ID: mdl-8274846

ABSTRACT

Gossypol, a natural racemic mixture with action on NADP- and NAD-oxidoreductases from diverse species, has been proposed as a possible antiamebic medication considering several of its pharmacological properties. In this study it was found that malic enzyme and alcohol dehydrogenase from Entamoeba histolytica are strongly inhibited by (+/-)-gossypol, and both (+)- and (-)- enantiomers. The inhibition was of the noncompetitive type among their respective substrates in all cases. The (+/-), (+)-, (-)-gossypol half-maximal inhibitory concentrations (IC50) for the malic enzyme were 3.71, 13.37 and 1.03 microM, and against the alcohol dehydrogenase 79.64, 124.43 and 42.56 microM, respectively. Therefore, the (-) enantiomer resulted 3.6 and 13.0 times more potent than the racemic mixture and (+)-gossypol, respectively, to inhibit the malic enzyme, and 1.9 times and 2.9 times more potent than the racemic mixture and (+)-gossypol, respectively, against the alcohol dehydrogenase. Accordingly, one possible mechanism of the antiamebic effect of gossypol could be the inhibition of vital NADP-dependent enzymes as those analyzed in this study.


Subject(s)
Entamoeba histolytica/drug effects , Gossypol/pharmacology , Alcohol Dehydrogenase/antagonists & inhibitors , Amebicides/pharmacology , Animals , Entamoeba histolytica/enzymology , Gossypol/chemistry , Malate Dehydrogenase/antagonists & inhibitors , Stereoisomerism
19.
Parasitol Res ; 79(3): 200-3, 1993.
Article in English | MEDLINE | ID: mdl-8493243

ABSTRACT

Axenic HK9 Entamoeba histolytica strain amoebae, maintained in PEHS medium, displayed several cystic characteristics that involve an active process of cystic wall formation, cellular volume and density diminution, and one or two nuclear divisions. The differentiation process was asynchronic, beginning after the logarithmic growth phase. The axenic cysts, which were maintained in a 50 mOsm/kg medium at 4 degrees C for 72 h, produced growing trophozoites within 1-7 days of incubation at 36 degrees C in fresh medium. Negative results were obtained with trophozoites submitted to the above treatment, and with axenic cysts maintained in double-distilled water at 4 degrees C for 24 h, or in 0.1% sarkosyl, for 10 min at room temperature instead of 55 mosmol/kg medium. Thus, the HK9 E. histolytica strain, cultured in PEHPS, produced under axenic conditions a small proportion of mature, metabolically active cysts, but with an immature or abnormal wall.


Subject(s)
Entamoeba histolytica/growth & development , Entamoeba histolytica/ultrastructure , Animals , Cell Differentiation , Cell Membrane/ultrastructure , Culture Media , Entamoeba histolytica/metabolism , Male , Rabbits
20.
Arch Med Res ; 23(2): 69-70, 1992.
Article in English | MEDLINE | ID: mdl-1340324

ABSTRACT

Gossypol has an in vitro antiamebic effect, which is 11,39, and 980 times more potent than emetime, metronidazole and diiodohydroxyquinolein, respectively, on five Entamoeba histolytica axenic strains. The trophozoite NADP-dependent malic enzyme and alcohol dehydrogenase are inhibited by (+/-)-gossypol, in a noncompetitive manner with respect to the substrate. From the (-)- and (+)- enantiomers, which integrate the natural gossypol mixture, the first one is three and four times more active in inhibiting both the amebic culture growth and the mentioned oxidoreductases, respectively. The above results justify the analysis of gossypol as an antiamebic drug in experimentally infected animals.


Subject(s)
Alcohol Oxidoreductases/antagonists & inhibitors , Amebicides/pharmacology , Entamoeba histolytica/drug effects , Gossypol/pharmacology , Malate Dehydrogenase/antagonists & inhibitors , Protozoan Proteins/antagonists & inhibitors , Animals , Entamoeba histolytica/growth & development , Isomerism
SELECTION OF CITATIONS
SEARCH DETAIL
...